Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 255 | 223 | 254 | 149 | 135 |
| Accounts receivable | -38 | 254 | 20 | 10 | -558 |
| Other Working Capital | 170 | 1,731 | 1,072 | -573 | -484 |
| Other Operating Activity | -6,954 | -3,424 | -5,606 | -4,467 | -4,137 |
| Operating Cash Flow | $-6,566 | $-1,216 | $-4,260 | $-4,880 | $-5,044 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -533 | -134 | -410 | -295 | -248 |
| Investing Cash Flow | $-533 | $-134 | $-410 | $-295 | $-248 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -60 | N/A | N/A | 0 | 0 |
| Common Stock Issued | 17,482 | 2,089 | 0 | 3,804 | 7,002 |
| Other Financing Activity | 1,193 | 40 | 1,954 | 0 | 709 |
| Financing Cash Flow | $18,615 | $2,129 | $1,954 | $3,804 | $7,711 |
| Beginning Cash Position | 1,034 | 254 | 2,970 | 4,341 | 1,922 |
| End Cash Position | 12,549 | 1,034 | 254 | 2,970 | 4,341 |
| Net Cash Flow | $11,515 | $780 | $-2,716 | $-1,371 | $2,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,566 | -1,216 | -4,260 | -4,880 | -5,044 |
| Capital Expenditure | -533 | -134 | -410 | -296 | -248 |
| Free Cash Flow | -7,100 | -1,349 | -4,670 | -5,177 | -5,293 |